|
|
Volumn 7, Issue 6, 1998, Pages 1015-1021
|
|
American Association for Cancer Research 1998: Promises and prospects for the next century
|
|
Author keywords
Cancer; Cytostatic cytotoxic agents
|
|
Indexed keywords
2 (3 CHLOROANILINO) 4 [2 (3 HYDROXYPROPYLAMINO) 4 PYRIDYL]PYRIMIDINE;
ANGIOGENESIS INHIBITOR;
ANGIOSTATIN;
CGP 59326;
ELEUTHEROBIN;
EPIDERMAL GROWTH FACTOR RECEPTOR;
FJ 5002;
IMATINIB;
LAULIMOLIDE;
LONAFARNIB;
N [4 (3 BROMOANILINO) 6 QUINAZOLINYL]ACRYLAMIDE;
PD 169414;
PD 169451;
PROTEIN FARNESYLTRANSFERASE;
PROTEIN FARNESYLTRANSFERASE INHIBITOR;
PROTEIN KINASE INHIBITOR;
PROTEIN TYROSINE KINASE INHIBITOR;
SEMAXANIB;
THROMBOCYTE FACTOR 4;
TIPIFARNIB;
TRANSFERASE INHIBITOR;
UNCLASSIFIED DRUG;
VASCULOTROPIN RECEPTOR;
ANGIOGENESIS;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CANCER;
CANCER RESEARCH;
CLINICAL TRIAL;
DRUG DEVELOPMENT;
HUMAN;
PHASE 1 CLINICAL TRIAL;
STRUCTURE ACTIVITY RELATION;
TUMOR CELL LINE;
TUMOR RESISTANCE;
|
|
EID: 0031838638
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.7.6.1015 Document Type: Article |
|
Times cited : (8)
|
|
References (33)
|
